Mental Illness – Medical Marijuana

Therapeutical use of the cannabinoids in psychiatry

By admin| 2016-07-06T10:20:56+01:00 July 6th, 2016|

The endocannabinoid system and emotional Processing- A pharmacological fMRI study with D9-tetrahydrocannabinol

By admin| 2016-07-06T10:20:15+01:00 July 6th, 2016|

The Development of Cannabidiol as a Psychiatric Therapeutic- A Review of Its Antipsychotic Efficacy and Possible Underlying Pharmacodynamic Mechanisms

By admin| 2016-07-06T10:19:12+01:00 July 6th, 2016|

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis- involvement of the endocannabinoid system

By admin| 2016-07-06T10:18:06+01:00 July 6th, 2016|

Progress in Neuro-Psychopharmacology & Biological Psychiatry

By admin| 2016-07-06T10:17:14+01:00 July 6th, 2016|

Opposite Effects of D-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

By admin| 2016-07-06T10:16:27+01:00 July 6th, 2016|

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder_ a preliminary report – ResearchGate

By admin| 2016-07-06T10:15:33+01:00 July 6th, 2016|

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

By admin| 2016-07-06T10:14:05+01:00 July 6th, 2016|

Motor effects of delta 9 THC in cerebellar Lurcher mutant mice

By admin| 2016-07-06T10:12:38+01:00 July 6th, 2016|

Long term marijuana users seeking medical cannabis in California (2001–2007)- demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants

By admin| 2016-07-06T10:10:47+01:00 July 6th, 2016|

1 2 3 Next